Seroprevalence of Neutralizing Antibodies Against HFMD Associated Enteroviruses Among Healthy Individuals in Shanghai, China, 2022

Overview

Journal Virol Sin

Specialty Microbiology

Date 2024 May 27

PMID 38801978

Authors

Jiayu Wang

Wencheng Wu

Wei Wang

Jingyi Zhang

Jianwei Xiao

Mingyi Cai

Jiaying Guo

Run Li

Shuangli Zhu

Wanju Zhang

Min Chen

Zheng Teng

Affiliations

Soon will be listed here.

References

Zhou Y, Zhou J, Yang J, Qiu Q, Wang L, Yang J . Comparison of Neutralizing Antibody Response Kinetics in Patients with Hand, Foot, and Mouth Disease Caused by Coxsackievirus A16 or Enterovirus A71: A Longitudinal Cohort Study of Chinese Children, 2017-2019. J Immunol. 2022; 209(2):280-287. DOI: 10.4049/jimmunol.2200143. View

Zhu R, Cheng T, Yin Z, Liu D, Xu L, Li Y . Serological survey of neutralizing antibodies to eight major enteroviruses among healthy population. Emerg Microbes Infect. 2018; 7(1):2. PMC: 5837151. DOI: 10.1038/s41426-017-0003-z. View

Wang J, Zhu S, Wang J, Lin Y, Pei Y, Sun D . Seroprevalence of Enterovirus A71 and Coxsackievirus A16 in Healthy People in Shandong Province, China. PLoS One. 2016; 11(9):e0162373. PMC: 5017641. DOI: 10.1371/journal.pone.0162373. View

Yang B, Liu F, Liao Q, Wu P, Chang Z, Huang J . Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine. Euro Surveill. 2017; 22(50). PMC: 5743100. DOI: 10.2807/1560-7917.ES.2017.22.50.16-00824. View

Gao F, Bian L, Chen L, Zhou Y, Li G, Mao Q . A cross-sectional seroepidemiology study of seven major enteroviruses causing HFMD in Guangdong, China. J Infect. 2021; 83(1):119-145. DOI: 10.1016/j.jinf.2021.04.011. View

Zhou Y, Tan L, Luo K, Liao Q, Wang L, Qiu Q . Genetic Variation of Multiple Serotypes of Enteroviruses Associated with Hand, Foot and Mouth Disease in Southern China. Virol Sin. 2020; 36(1):61-74. PMC: 7385209. DOI: 10.1007/s12250-020-00266-7. View

Wang J, Teng Z, Cui X, Li C, Pan H, Zheng Y . Epidemiological and serological surveillance of hand-foot-and-mouth disease in Shanghai, China, 2012-2016. Emerg Microbes Infect. 2018; 7(1):8. PMC: 5837173. DOI: 10.1038/s41426-017-0011-z. View

Zhu F, Meng F, Li J, Li X, Mao Q, Tao H . Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013; 381(9882):2024-32. DOI: 10.1016/S0140-6736(13)61049-1. View

Shen L, Sun M, Song S, Hu Q, Wang N, Ou G . The impact of anti-COVID-19 nonpharmaceutical interventions on hand, foot, and mouth disease-A spatiotemporal perspective in Xi'an, northwestern China. J Med Virol. 2022; 94(7):3121-3132. PMC: 9088661. DOI: 10.1002/jmv.27715. View

10.

Wang J, Liu J, Fang F, Wu J, Ji T, Yang Y . Genomic surveillance of coxsackievirus A10 reveals genetic features and recent appearance of genogroup D in Shanghai, China, 2016-2020. Virol Sin. 2022; 37(2):177-186. PMC: 9170976. DOI: 10.1016/j.virs.2022.01.028. View

11.

Huang W, Huang L, Kao C, Lu C, Shao P, Cheng A . Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city. J Microbiol Immunol Infect. 2011; 45(2):96-101. DOI: 10.1016/j.jmii.2011.09.025. View

12.

Li P, Chen Y, Tang A, Gao F, Yan J . Seroprevalence of coxsackievirus A16 antibody among people of various age groups: a systematic review and meta-analysis. Arch Public Health. 2021; 79(1):166. PMC: 8447778. DOI: 10.1186/s13690-021-00688-z. View

13.

Geng Y, Zhang L . Impact of non-pharmaceutical interventions during COVID-19 pandemic on pertussis, scarlet fever and hand-foot-mouth disease in China. J Infect. 2021; 84(2):e13-e15. PMC: 8694816. DOI: 10.1016/j.jinf.2021.12.023. View